Log in to save to my catalogue

Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic...

Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8738154

Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer

About this item

Full title

Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer

Publisher

London: Nature Publishing Group UK

Journal title

Oncogene, 2022-01, Vol.41 (2), p.260-267

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Loss-of-function alterations of
Neurofibromin 1
(
NF1
) activate RAS, a driver of colorectal cancer. However, the clinical implications of
NF1
alterations are largely unknown. We performed a comprehensive molecular profiling of
NF1
-mutant colorectal cancer using data from 8150 patients included in a dataset of commercial CL...

Alternative Titles

Full title

Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8738154

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8738154

Other Identifiers

ISSN

0950-9232

E-ISSN

1476-5594

DOI

10.1038/s41388-021-02074-z

How to access this item